The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sekisui Chemical Co Ltd
F:SUI
|
JP |
|
Ampeak Energy Ltd
F:7K8
|
UK |
|
A
|
Advanced Connection Corporation PCL
SET:ACC
|
TH |
|
B
|
Blu Label Unlimited Group Ltd
XMUN:5TP
|
ZA |
|
S
|
Sociedad Comercial del Plata SA
BCBA:COME
|
AR |
|
Daiichi Life Group Inc
OTC:DCNSF
|
JP |
|
Bukit Uluwatu Villa Tbk PT
IDX:BUVA
|
ID |
|
Lonza Group AG
SIX:LONN
|
CH |
|
S
|
Spero Therapeutics Inc
F:2HA
|
US |
|
Mindteck (India) Ltd
BSE:517344
|
IN |
|
Nitori Holdings Co Ltd
TSE:9843
|
JP |
|
C
|
Connected Minerals Ltd
ASX:CML
|
AU |
|
A
|
Applied Materials Inc
SWB:AP2
|
US |
|
L
|
Lam Research Corp
F:LAR0
|
US |
|
Philip Morris International Inc
NYSE:PM
|
US |
|
COG Financial Services Ltd
ASX:COG
|
AU |
|
E
|
Eckert & Ziegler SE
XMUN:EUZ
|
DE |
|
Omnicell Inc
NASDAQ:OMCL
|
US |
|
I
|
International Bancshares Corp
F:IB4
|
US |
|
D
|
Daiichi Life Group Inc
F:QHH
|
JP |
|
E
|
Electromagnetic Geoservices ASA
XMUN:E2M
|
NO |
|
ABM Investama Tbk PT
F:0A1
|
ID |
|
C
|
Carlisle Companies Inc
F:CLE
|
US |
|
M
|
Morgan Stanley
XMUN:DWD
|
US |
Sekisui Chemical Co Ltd (SUI)’s 12-month stock price forecast through November 2027 has a consensus target of €17.42, implying 18% upside. The forecast is based on price targets from 9 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
SUI is 17.42 EUR with a low forecast of 14.16 EUR and a high forecast of 20.07 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next -3 years is 3%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 11%.
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 9%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more